If you vaguely follow big pharma, then you have probably heard of something called a patent cliff, which is when a company has multiple patents expiring within a short timeframe. Though patent expiration may be better forHello, my name is Joseph "Kade" Minton, I prefer to go by Kade, and I enjoy writing, researching, and investing in speculative growth stocks that I think are undervalued or simply misunderstood. In particular, I think the biotech sector is on the cusp of a golden era with revolutionary brea ...

文章核心观点 - 作者认为生物技术行业正处于一个黄金时代的开端 预计将在短期内见证包括癌症、阿尔茨海默病和一系列自身免疫性疾病在内的多种疾病被治愈或得到有效治疗[1] - 作者同时指出技术领域正在以超音速般的速度发展 预计核聚变能源、固态电池和纳米材料等技术将很快普及[1] 作者背景与研究方法 - 作者拥有工程物理和应用数学背景 目前从事环境和工业合规工作[1] - 作者的研究方法结合了定量模型和宏观分析 定量模型运用了微分方程和线性代数等高等数学概念 同时也会考虑历史监管先例等宏观因素[1] - 作者专注于研究和投资其认为被低估或被误解的投机性成长股 特别是生物技术领域的股票[1]